Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers
暂无分享,去创建一个
Sharadwata Pan | Michael K Danquah | Kei Xian Tan | Jaison Jeevanandam | M. Danquah | Sharadwata Pan | J. Jeevanandam
[1] S. Nagaraja,et al. Impact of nitinol stent surface processing on in-vivo nickel release and biological response. , 2018, Acta biomaterialia.
[2] A. Aravind,et al. Aptamer-labeled PLGA nanoparticles for targeting cancer cells , 2012, Cancer Nanotechnology.
[3] Thommey P. Thomas,et al. Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy. , 2004, Bioconjugate chemistry.
[4] Bing Li,et al. Zinc oxide nanoparticle-induced atherosclerotic alterations in vitro and in vivo , 2017, International journal of nanomedicine.
[5] Dipanjan Pan,et al. 3D‐Printed Multidrug‐Eluting Stent from Graphene‐Nanoplatelet‐Doped Biodegradable Polymer Composite , 2017, Advanced healthcare materials.
[6] V. Adam,et al. Selenium nanoparticles as a nutritional supplement. , 2017, Nutrition.
[7] Xiaoling Zhang,et al. Molecular Assembly of an Aptamer–Drug Conjugate for Targeted Drug Delivery to Tumor Cells , 2009, Chembiochem : a European journal of chemical biology.
[8] E. Zapp,et al. Label‐free Electrochemical Immunosensor for Cardiac Troponin T Based on Exfoliated Graphite Nanoplatelets Decorated with Gold Nanoparticles , 2017 .
[9] A. Aravind,et al. Aptamer conjugated paclitaxel and magnetic fluid loaded fluorescently tagged PLGA nanoparticles for targeted cancer therapy , 2013 .
[10] J. Fallon,et al. Dexamethasone inhibits macrophage accumulation after balloon arterial injury in cholesterol fed rabbits. , 2001, Atherosclerosis.
[11] Elliot L Chaikof,et al. Microfabrication and nanotechnology in stent design. , 2011, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[12] Joshua Y. S. Chan,et al. Development of a DNA aptamer for direct and selective homocysteine detection in human serum , 2013 .
[13] Kit S Lam,et al. Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery. , 2011, Biomaterials.
[14] Xiaoyang Xu,et al. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.
[15] F. Liu,et al. Initial study of sediment antagonism and characteristics of silver nanoparticle-coated biliary stents in an experimental animal model , 2016, International journal of nanomedicine.
[16] H. Daraee,et al. Cardioprotective effect of magnetic hydrogel nanocomposite loaded N,α-L-rhamnopyranosyl vincosamide isolated from Moringa oleifera leaves against doxorubicin-induced cardiac toxicity in rats: in vitro and in vivo studies , 2017, Journal of microencapsulation.
[17] Kei Xian Tan,et al. Aptamer-Mediated Polymeric Vehicles for Enhanced Cell-Targeted Drug Delivery. , 2016, Current drug targets.
[18] Shuqi Wang,et al. Nanomaterial-based biosensors for measurement of lipids and lipoproteins towards point-of-care of cardiovascular disease. , 2017, The Analyst.
[19] S. Ganta,et al. A review of stimuli-responsive nanocarriers for drug and gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[20] Xiaohua Huang,et al. Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. , 2008, Accounts of chemical research.
[21] Kinam Park,et al. Drug delivery of the future: Chasing the invisible gorilla. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[22] Masaaki Kai,et al. DNA Aptamers in the Diagnosis and Treatment of Human Diseases , 2015, Molecules.
[23] D. Jaque,et al. Quantum Dots Emitting in the Third Biological Window as Bimodal Contrast Agents for Cardiovascular Imaging , 2017 .
[24] Kemin Wang,et al. Sensitive point-of-care monitoring of cardiac biomarker myoglobin using aptamer and ubiquitous personal glucose meter. , 2015, Biosensors & bioelectronics.
[25] Can Zhang,et al. Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids. , 2013, Biomaterials.
[26] James Margolis,et al. Systemic Nanoparticle Paclitaxel (nab‐Paclitaxel) for In‐stent Restenosis I (SNAPIST‐I): A First‐in‐Human Safety and Dose‐finding Study , 2007, Clinical cardiology.
[27] Benjamin Chu,et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts , 2007, Proceedings of the National Academy of Sciences.
[28] Guixue Wang,et al. Controlled Slow-Release Drug-Eluting Stents for the Prevention of Coronary Restenosis: Recent Progress and Future Prospects. , 2015, ACS applied materials & interfaces.
[29] S. Wickline,et al. Thrombin‐inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis , 2011, Journal of thrombosis and haemostasis : JTH.
[30] Jacek Otlewski,et al. Aptamers: molecules of great potential. , 2013, Biotechnology advances.
[31] Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries. , 2009, JACC. Cardiovascular interventions.
[32] Esther K Zondervan-van den Beuken,et al. A practical approach to assess inhalation toxicity of metal oxide nanoparticles in vitro , 2018, Journal of applied toxicology : JAT.
[33] Parkson Lee-Gau Chong,et al. Targeting VEGF‐encapsulated immunoliposomes to MI heart improves vascularity and cardiac function , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] E. Kauppinen,et al. Injected nanoparticles: the combination of experimental systems to assess cardiovascular adverse effects. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[35] Mark S. Bolding,et al. In vitro studies of heparin-coated magnetic nanoparticles for use in the treatment of neointimal hyperplasia. , 2018, Nanomedicine : nanotechnology, biology, and medicine.
[36] Pasquale Totaro,et al. Efficacy of antimicrobial activity of slow release silver nanoparticles dressing in post-cardiac surgery mediastinitis. , 2008, Interactive cardiovascular and thoracic surgery.
[37] U. Sechtem,et al. Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now? , 2016, International journal of nanomedicine.
[38] X. Tang,et al. Carbon nanomaterial-enhanced scaffolds for the creation of cardiac tissue constructs: A new frontier in cardiac tissue engineering , 2017 .
[39] A. Schober,et al. MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease , 2016, Circulation.
[40] Non-polymer drug-eluting coronary stents , 2018, Drug Delivery and Translational Research.
[41] Luigi Martino,et al. Stability and binding properties of a modified thrombin binding aptamer. , 2008, Biophysical journal.
[42] D. Gailani,et al. Update on the physiology and pathology of factor IX activation by factor XIa , 2008, Expert review of hematology.
[43] P. P. Lottici,et al. Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.
[44] R. Virmani,et al. Sustained Reduction of In-Stent Neointimal Growth With the Use of a Novel Systemic Nanoparticle Paclitaxel , 2002, Circulation.
[45] E. Goldys,et al. Nanocomposites of gold nanoparticles and graphene oxide towards an stable label-free electrochemical immunosensor for detection of cardiac marker troponin-I. , 2016, Analytica chimica acta.
[46] D. Wagner,et al. Inhibition of von Willebrand factor‐mediated platelet activation and thrombosis by the anti‐von Willebrand factor A1‐domain aptamer ARC1779 , 2009, Journal of thrombosis and haemostasis : JTH.
[47] Eun Seong Lee,et al. Polymeric nanovehicles for anticancer drugs with triggering release mechanisms , 2007 .
[48] Ralph Weissleder,et al. A light-activated theranostic nanoagent for targeted macrophage ablation in inflammatory atherosclerosis. , 2010, Small.
[49] F. Cohen,et al. Biochemistry and genetics of von Willebrand factor. , 1998, Annual review of biochemistry.
[50] 小林 四郎,et al. Encyclopedia of Polymeric Nanomaterials , 2015 .
[51] J. M. Healy,et al. First-inHuman Evaluation of Anti – von Willebrand Factor Therapeutic Aptamer ARC 1779 in Healthy Volunteers , 2007 .
[52] Kit S Lam,et al. Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols. , 2012, Angewandte Chemie.
[53] T. Webster,et al. Poly(lactic-co-glycolic acid): carbon nanofiber composites for myocardial tissue engineering applications. , 2011, Acta biomaterialia.
[54] P. Yadava,et al. Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics , 2014, BioMed research international.
[55] B. Hong,et al. Graphene oxide flakes as a cellular adhesive: prevention of reactive oxygen species mediated death of implanted cells for cardiac repair. , 2015, ACS nano.
[56] B. Sullenger,et al. A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[57] D. Fremont,et al. A structural explanation for the antithrombotic activity of ARC1172, a DNA aptamer that binds von Willebrand factor domain A1. , 2009, Structure.
[58] Young-Pil Kim,et al. Detection and Characterization of Cancer Cells and Pathogenic Bacteria Using Aptamer-Based Nano-Conjugates , 2014, Sensors.
[59] E. Tavares,et al. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit. , 2008, Atherosclerosis.
[60] W. Geldenhuys,et al. Drug Delivery and Nanoformulations for the Cardiovascular System. , 2017, Research & reviews. Drug delivery.
[61] R. N. Saha,et al. Nanoparticulate drug delivery systems for cancer chemotherapy , 2010, Molecular membrane biology.
[62] Vahid Azimirad,et al. The cardiac effects of carbon nanotubes in rat , 2016, BioImpacts : BI.
[63] Geoffrey S Baird,et al. Where are all the aptamers? , 2010, American journal of clinical pathology.
[64] T. Hyeon,et al. Iron oxide nanoparticle-mediated development of cellular gap junction crosstalk to improve mesenchymal stem cells' therapeutic efficacy for myocardial infarction. , 2015, ACS nano.
[65] R. Mittal,et al. Recent treatment modalities for cardiovascular diseases with a focus on stem cells, aptamers, exosomes and nanomedicine , 2018, Artificial cells, nanomedicine, and biotechnology.
[66] B. Nemery,et al. Do Nanomedicines Require Novel Safety Assessments to Ensure their Safety for Long-Term Human Use? , 2009, Drug safety.
[67] E. Fort,et al. Gold nanoparticles in cardiovascular imaging. , 2018, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[68] Susheel Kumar Nethi,et al. Bioconjugated gold nanoparticles accelerate the growth of new blood vessels through redox signaling. , 2014, Chemical communications.
[69] T. Stinchcombe,et al. Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel. , 2007, Nanomedicine.
[70] Robert Langer,et al. Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. , 2008, ACS nano.
[71] K. Egashira,et al. Nanoparticle-mediated drug delivery system for atherosclerotic cardiovascular disease. , 2017, Journal of cardiology.
[72] V. Fuster,et al. Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis. , 2010, Molecular pharmaceutics.
[73] T. Webster,et al. Enhanced endothelial cell functions on rosette nanotube-coated titanium vascular stents , 2009, International journal of nanomedicine.
[74] N. Erk,et al. A novel electrochemical nano-platform based on graphene/platinum nanoparticles/nafion composites for the electrochemical sensing of metoprolol , 2017 .
[75] Brian D. MacCraith,et al. Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications , 2011, Cellular and Molecular Life Sciences.
[76] E. Vermaas,et al. Selection of single-stranded DNA molecules that bind and inhibit human thrombin , 1992, Nature.
[77] G. Wallukat,et al. Aptamer Neutralization of Beta1-Adrenoceptor Autoantibodies Isolated From Patients With Cardiomyopathies , 2011, Circulation research.
[78] Zhihong Wang,et al. Application of magnetic Cd2+ ion-imprinted mesoporous organosilica nanocomposites for mineral wastewater treatment , 2017 .
[79] Y. Zu,et al. Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy , 2014, Molecular therapy. Nucleic acids.
[80] A. Deep,et al. Gold nanoparticles-reduced graphene oxide based electrochemical immunosensor for the cardiac biomarker myoglobin , 2016, Microchimica Acta.
[81] J. Kucińska-Lipka,et al. Fabrication of polyurethane and polyurethane based composite fibres by the electrospinning technique for soft tissue engineering of cardiovascular system. , 2015, Materials science & engineering. C, Materials for biological applications.
[82] L. Forró,et al. Cellular toxicity of carbon-based nanomaterials. , 2006, Nano letters.
[83] Ying Li,et al. Shape effect in cellular uptake of PEGylated nanoparticles: comparison between sphere, rod, cube and disk. , 2015, Nanoscale.
[84] Kinam Park. The drug delivery field at the inflection point: Time to fight its way out of the egg , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[85] Min Wu,et al. Aptamers: Active Targeting Ligands for Cancer Diagnosis and Therapy , 2015, Theranostics.
[86] I. Fishbein,et al. Macrophage Depletion by Clodronate-Containing Liposomes Reduces Neointimal Formation After Balloon Injury in Rats and Rabbits , 2002, Circulation.
[87] V. Kholodovych,et al. Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo , 2015, Proceedings of the National Academy of Sciences.
[88] W Cai,et al. Aptamers as therapeutics in cardiovascular diseases. , 2011, Current medicinal chemistry.
[89] S. Pocock,et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. , 2007, The New England journal of medicine.
[90] J. Herbert,et al. Investigation of the selectivity of thrombin-binding aptamers for thrombin titration in murine plasma. , 2016, Biosensors & bioelectronics.
[91] C D Claussen,et al. Aptamer-based isolation and subsequent imaging of mesenchymal stem cells in ischemic myocard by magnetic resonance imaging. , 2007, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[92] Maria C. DeRosa,et al. Challenges and Opportunities for Small Molecule Aptamer Development , 2012, Journal of nucleic acids.
[93] Ian Trase,et al. Design of Nanoparticle-Based Carriers for Targeted Drug Delivery. , 2016, Journal of nanomaterials.
[94] Peng Li,et al. Niosome Encapsulation of Curcumin , 2016 .
[95] Samuel A. Wickline,et al. Endothelial &agr;&ngr;&bgr;3 Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis , 2006 .
[96] Mark H Wholey,et al. Updated review of the global carotid artery stent registry , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[97] Kun-He Zhang,et al. The modulation of coagulation by aptamers: an up-to-date review , 2015, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[98] X. Lan,et al. Development of aptamer oligonucleotides as anticoagulants and antithrombotics for cardiovascular diseases: current status. , 2014, Thrombosis research.
[99] J. M. Healy,et al. First-in-Human Evaluation of Anti–von Willebrand Factor Therapeutic Aptamer ARC1779 in Healthy Volunteers , 2007, Circulation.
[100] Junchao Duan,et al. Low-dose exposure of silica nanoparticles induces cardiac dysfunction via neutrophil-mediated inflammation and cardiac contraction in zebrafish embryos , 2016, Nanotoxicology.
[101] M Jones,et al. Evaluation of explanted polyurethane trileaflet cardiac valve prostheses. , 1987, The Journal of thoracic and cardiovascular surgery.
[102] G. Bayramoglu,et al. Pathogen detection by core-shell type aptamer-magnetic preconcentration coupled to real-time PCR. , 2014, Analytical biochemistry.
[103] Thomas Zeller,et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. , 2005, Journal of vascular and interventional radiology : JVIR.
[104] J. Leor,et al. Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair , 2011, Proceedings of the National Academy of Sciences.
[105] A. Seifalian,et al. Effect of prolonged pulsatile shear stress in vitro on endothelial cell seeded PTFE and compliant polyurethane vascular grafts. , 1998, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[106] Shelton D Caruthers,et al. Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis. , 2008, JACC. Cardiovascular imaging.
[107] S. King,et al. Nobori stent shows less vascular inflammation and early recovery of endothelial function compared with Cypher stent. , 2012, JACC. Cardiovascular interventions.
[108] Jeffrey M. Caves,et al. The evolving impact of microfabrication and nanotechnology on stent design. , 2006, Journal of vascular surgery.
[109] Manabu T. Nakamura,et al. Synthetic dimyristoylphosphatidylcholine liposomes assimilating into high-density lipoprotein promote regression of atherosclerotic lesions in cholesterol-fed rabbits , 2010, Experimental biology and medicine.
[110] Kemin Wang,et al. DNA aptamer-based surface plasmon resonance sensing of human C-reactive protein , 2014 .
[111] Y. Shen,et al. Investigation into the pulmonary inflammopathology of exposure to nickel oxide nanoparticles in mice. , 2017, Nanomedicine : nanotechnology, biology, and medicine.
[112] A. Kharlamov,et al. Silica-gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial. , 2015, Nanoscale.
[113] Paurush Ambesh,et al. Nanomedicine in coronary artery disease , 2017, Indian heart journal.
[114] Xinmai Yang,et al. Molecular photoacoustic tomography with colloidal nanobeacons. , 2009, Angewandte Chemie.
[115] A. Shrivastava,et al. C-reactive protein, inflammation and coronary heart disease , 2015 .
[116] M. Meyyappan,et al. Label-free detection of cardiac troponin-I using carbon nanofiber based nanoelectrode arrays. , 2013, Analytical chemistry.
[117] V. Guillard,et al. How the shape of fillers affects the barrier properties of polymer/non-porous particles nanocomposites: A review , 2018, Journal of Membrane Science.
[118] Wei Yao,et al. Formation of microcapsules by ultrasound stimulation for use in remote-controlled drug-eluting stents. , 2018, Medical engineering & physics.
[119] Mauricio G. Cohen,et al. The REG1 anticoagulation system: a novel actively controlled factor IX inhibitor using RNA aptamer technology for treatment of acute coronary syndrome. , 2012, Future cardiology.
[120] Liming Dai,et al. DNA damage induced by multiwalled carbon nanotubes in mouse embryonic stem cells. , 2007, Nano letters.
[121] K. Raghu,et al. Selenium incorporated guar gum nanoparticles safeguard mitochondrial bioenergetics during ischemia reperfusion injury in H9c2 cardiac cells. , 2018, International journal of biological macromolecules.
[122] V. Torchilin,et al. Environment-responsive multifunctional liposomes. , 2010, Methods in molecular biology.
[123] D. Letourneur,et al. Thrombosis Treatment: Development of Polymer Microcapsules Functionalized with Fucoidan to Target P‐Selectin Overexpressed in Cardiovascular Diseases (Adv. Healthcare Mater. 4/2017) , 2017 .
[124] Endothelial-cell-binding aptamer for coating of intracoronary stents. , 2010, The Journal of invasive cardiology.
[125] Kemin Wang,et al. Screening of DNA aptamers against myoglobin using a positive and negative selection units integrated microfluidic chip and its biosensing application. , 2014, Analytical chemistry.
[126] Agnes Aruna John,et al. Multifaceted prospects of nanocomposites for cardiovascular grafts and stents , 2015, International journal of nanomedicine.
[127] J. Kim,et al. Prospects for nucleic acid-based therapeutics against hepatitis C virus. , 2013, World journal of gastroenterology.
[128] S. Mccurdy,et al. The single-stranded DNA aptamer-binding site of human thrombin. , 1993, The Journal of biological chemistry.
[129] R. Linhardt,et al. Polysaccharide-based nanocomposites and their applications. , 2015, Carbohydrate research.
[130] Ho Sup Yoon,et al. Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer , 2006, Nature materials.
[131] Nuo Duan,et al. A dual-color flow cytometry protocol for the simultaneous detection of Vibrio parahaemolyticus and Salmonella typhimurium using aptamer conjugated quantum dots as labels. , 2013, Analytica chimica acta.
[132] P. Scarborough,et al. Cardiovascular disease in Europe 2014: epidemiological update. , 2014, European heart journal.
[133] M. Ramezani,et al. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro. , 2015, International journal of pharmaceutics.
[134] J. Mehilli,et al. Polymer-free drug-eluting stents for coronary artery disease. , 2018, Journal of interventional cardiology.
[135] Yasuhiko Yoshida,et al. AS1411 aptamer tagged PLGA‐lecithin‐PEG nanoparticles for tumor cell targeting and drug delivery , 2012, Biotechnology and bioengineering.
[136] Erkki Ruoslahti,et al. Targeting atherosclerosis by using modular, multifunctional micelles , 2009, Proceedings of the National Academy of Sciences.
[137] J. Meng,et al. Improving the blood compatibility of polyurethane using carbon nanotubes as fillers and its implications to cardiovascular surgery. , 2005, Journal of biomedical materials research. Part A.
[138] A. Stroyuk,et al. Plasmonic gold nanoparticles possess the ability to open potassium channels in rat thoracic aorta smooth muscles in a remote control manner. , 2015, Vascular pharmacology.
[139] S. Steinhubl,et al. First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology: A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the Controlled Regulation of Factor IXa Activity , 2006, Circulation.
[140] B. Brott,et al. A nitric oxide releasing, self assembled peptide amphiphile matrix that mimics native endothelium for coating implantable cardiovascular devices. , 2010, Biomaterials.
[141] K. Sundar,et al. A novel biocompatible chitosan-Selenium nanoparticles (SeNPs) film with electrical conductivity for cardiac tissue engineering application. , 2018, Materials science & engineering. C, Materials for biological applications.
[142] Sangjin Park,et al. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. , 2007 .
[143] Yongjia Liu,et al. Preparation of paclitaxel/chitosan co-assembled core-shell nanofibers for drug-eluting stent , 2017 .
[144] Kei Xian Tan,et al. Towards targeted cancer therapy: Aptamer or oncolytic virus? , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[145] A. DeAnda,et al. Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.
[146] Eckhard Salzsieder,et al. Aptamer BC007 for neutralization of pathogenic autoantibodies directed against G-protein coupled receptors: A vision of future treatment of patients with cardiomyopathies and positivity for those autoantibodies. , 2016, Atherosclerosis.
[147] Stephan Marsch,et al. Inhibition of Macrophage Phagocytotic Activity by a Receptor-targeted Polymer Vesicle-based Drug Delivery Formulation of Pravastatin , 2008, Journal of cardiovascular pharmacology.
[148] Tom Duerig,et al. Self-expanding nitinol stents: material and design considerations , 2004, European Radiology.
[149] Yuan Siang Lui,et al. Materials technology in drug eluting balloons: Current and future perspectives. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[150] L. Jaykus,et al. Nucleic acid aptamers for capture and detection of Listeria spp. , 2013, Journal of biotechnology.
[151] Tal Dvir,et al. Nanoparticles targeting the infarcted heart. , 2011, Nano letters.
[152] S. Salazar-García,et al. Role of silver nanoparticles (AgNPs) on the cardiovascular system , 2014, Archives of Toxicology.
[153] S. Chiou,et al. The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs , 2016 .
[154] K. Sundar,et al. Sodium selenite/selenium nanoparticles (SeNPs) protect cardiomyoblasts and zebrafish embryos against ethanol induced oxidative stress. , 2015, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[155] Yi Cao,et al. The adverse vascular effects of multi-walled carbon nanotubes (MWCNTs) to human vein endothelial cells (HUVECs) in vitro: role of length of MWCNTs , 2017, Journal of Nanobiotechnology.
[156] M. Kasra,et al. Cardiomyocyte behavior on biodegradable polyurethane/gold nanocomposite scaffolds under electrical stimulation. , 2016, Materials science & engineering. C, Materials for biological applications.
[157] Mahesh Kumar Joshi,et al. Processing and characterization of electrospun graphene oxide/polyurethane composite nanofibers for stent coating , 2015 .
[158] D. Dean,et al. Application of Gold Nanorods in Cardiovascular Science , 2017 .
[159] A. Deep,et al. Synthesis and preliminary therapeutic evaluation of copper nanoparticles against diabetes mellitus and -induced micro- (renal) and macro-vascular (vascular endothelial and cardiovascular) abnormalities in rats , 2016 .
[160] Daniel G. Anderson,et al. Therapeutic siRNA silencing in inflammatory monocytes , 2011, Nature Biotechnology.